Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts is a research paper published in Alzheimer's & Dementia (2018). On theSindex it has a DataRank of 7.9. It has been cited 290 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.851
From this paper's citation signal
Citation Network Contribution
7.1
From 180 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
Alzheimer Nederland
Grant: WE.15-2014-06
National Institutes of Health
Grant: K01 040197
National Institutes of Health
Grant: P01 AG036694
National Institutes of Health
Grant: P50 AG005134
National Institutes of Health
Grant: K23 EB019023
National Institutes of Health
Grant: K23 AG049087
National Institutes of Health
Grant: K24 AG035007
National Institutes of Health
Grant: R01EB014894
National Institutes of Health
Grant: R21 AG038994
National Institutes of Health
Grant: R01 AG026484
National Institutes of Health
Grant: R01 AG034556
National Institutes of Health
Grant: P50 AG00513421
National Institutes of Health
Grant: U19 AG10483
National Institutes of Health
Grant: R13 AG042201174210
National Institutes of Health
Grant: R01 AG027435
National Institutes of Health
Grant: R01 AG037497
U.S. Department of Defense
Grant: W81XWH-12-2-0012
Alzheimer's Association
Grant: ZEN-10-174210
Eli Lilly and Company
Grant: U01 AG032438
Eli Lilly and Company
Grant: U01 AG024904
Eli Lilly and Company
Grant: U19 AG010483
Additional file 2 of Race, APOE genotypes, and cognitive decline among middle-aged urban adults
Additional file 2 of Race, APOE genotypes, and cognitive decline among middle-aged urban adults
Additional file 1 of Race, APOE genotypes, and cognitive decline among middle-aged urban adults
Additional file 1 of Race, APOE genotypes, and cognitive decline among middle-aged urban adults
Additional file 1 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 1 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 2 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 2 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 3 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 3 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 4 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 4 of BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Additional file 1 of Relationship of sex differences in cortical thickness and memory among cognitively healthy subjects and individuals with mild cognitive impairment and Alzheimer disease
Additional file 1 of Relationship of sex differences in cortical thickness and memory among cognitively healthy subjects and individuals with mild cognitive impairment and Alzheimer disease
Additional file 1 of Regular proton pump inhibitor use and incident dementia: population-based cohort study
Additional file 1 of Regular proton pump inhibitor use and incident dementia: population-based cohort study
Additional file 1 of The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
Additional file 1 of The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
Additional file 2 of The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
Additional file 2 of The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury